• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢组学揭示了过氧化物酶体增殖物激活受体 α 在胆汁酸动态平衡中的重要作用。

Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis.

机构信息

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

出版信息

J Lipid Res. 2012 Aug;53(8):1625-35. doi: 10.1194/jlr.M027433. Epub 2012 Jun 4.

DOI:10.1194/jlr.M027433
PMID:22665165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3540854/
Abstract

Peroxisome proliferator-activated receptor α (PPARα) is a nuclear receptor that regulates fatty acid transport and metabolism. Previous studies revealed that PPARα can affect bile acid metabolism; however, the mechanism by which PPARα regulates bile acid homeostasis is not understood. In this study, an ultraperformance liquid chromatography coupled with electrospray ionization qua dru pole time-of-flight mass spectrometry (UPLC-ESI-QTOFMS)-based metabolomics approach was used to profile metabolites in urine, serum, and bile of wild-type and Ppara-null mice following cholic acid (CA) dietary challenge. Metabolomic analysis showed that the levels of several serum bile acids, such as CA (25-fold) and taurocholic acid (16-fold), were significantly increased in CA-treated Ppara-null mice compared with CA-treated wild-type mice. Phospholipid homeostasis, as revealed by decreased serum lysophos phati dylcholine (LPC) 16:0 (1.6-fold) and LPC 18:0 (1.6-fold), and corticosterone metabolism noted by increased urinary excretion of 11β-hydroxy-3,20-dioxopregn-4-en-21-oic acid (20-fold) and 11β,20α-dihydroxy-3-oxo-pregn-4-en-21-oic acid (3.6-fold), were disrupted in CA-treated Ppara-null mice. The hepatic levels of mRNA encoding transporters Abcb11, Abcb4, Abca1, Abcg5, and Abcg8 were diminished in Ppara-null mice, leading to the accumulation of bile acids in the liver during the CA challenge. These observations revealed that PPARα is an essential regulator of bile acid biosynthesis, transport, and secretion.

摘要

过氧化物酶体增殖物激活受体α(PPARα)是一种核受体,可调节脂肪酸的转运和代谢。先前的研究表明,PPARα 可以影响胆汁酸代谢;然而,PPARα 调节胆汁酸动态平衡的机制尚不清楚。在这项研究中,采用超高效液相色谱-电喷雾电离四极杆飞行时间质谱(UPLC-ESI-QTOFMS)代谢组学方法分析了给予胆酸(CA)饮食挑战后野生型和 Ppara 基因敲除(Ppara-null)小鼠的尿液、血清和胆汁中的代谢物。代谢组学分析表明,与 CA 处理的野生型小鼠相比,CA 处理的 Ppara-null 小鼠的几种血清胆汁酸水平(如 CA(25 倍)和牛磺胆酸(16 倍))显著增加。血清溶血磷脂酰胆碱(LPC)16:0(1.6 倍)和 LPC 18:0(1.6 倍)降低,以及皮质酮代谢物尿中 11β-羟基-3,20-二氧孕甾-4-烯-21-酸(20 倍)和 11β,20α-二羟基-3-氧孕甾-4-烯-21-酸(3.6 倍)排泄增加表明,CA 处理的 Ppara-null 小鼠中磷脂稳态被破坏。Ppara-null 小鼠肝内编码转运蛋白 Abcb11、Abcb4、Abca1、Abcg5 和 Abcg8 的 mRNA 水平降低,导致 CA 挑战期间胆汁酸在肝脏中积累。这些观察结果表明,PPARα 是胆汁酸生物合成、转运和分泌的必需调节剂。

相似文献

1
Metabolomics reveals an essential role for peroxisome proliferator-activated receptor α in bile acid homeostasis.代谢组学揭示了过氧化物酶体增殖物激活受体 α 在胆汁酸动态平衡中的重要作用。
J Lipid Res. 2012 Aug;53(8):1625-35. doi: 10.1194/jlr.M027433. Epub 2012 Jun 4.
2
Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.肝细胞过氧化物酶体增殖物激活受体α调节胆汁酸的合成与转运。
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1396-1411. doi: 10.1016/j.bbalip.2019.05.014. Epub 2019 Jun 10.
3
Gemfibrozil disrupts lysophosphatidylcholine and bile acid homeostasis via PPARα and its relevance to hepatotoxicity.吉非贝齐通过过氧化物酶体增殖物激活受体α(PPARα)破坏溶血磷脂酰胆碱和胆汁酸稳态及其与肝毒性的相关性。
Arch Toxicol. 2014 Apr;88(4):983-96. doi: 10.1007/s00204-013-1188-0. Epub 2014 Jan 3.
4
Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.过氧化物酶体增殖物激活受体α对脂肪酸和胆汁酸代谢的调节可预防酒精性肝病。
Alcohol Clin Exp Res. 2014 Jun;38(6):1520-31. doi: 10.1111/acer.12424. Epub 2014 Apr 28.
5
Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge.在 Fxr 基因敲除小鼠的尿液代谢组学研究中发现,在胆汁酸刺激下激活了适应性代谢途径。
J Lipid Res. 2010 May;51(5):1063-74. doi: 10.1194/jlr.M002923. Epub 2009 Nov 9.
6
Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation.过氧化物酶体增殖物激活受体α表达与激活的生物标志物的代谢组学和基因分析
Mol Endocrinol. 2007 Sep;21(9):2136-51. doi: 10.1210/me.2007-0150. Epub 2007 Jun 5.
7
Dual action of peroxisome proliferator-activated receptor alpha in perfluorodecanoic acid-induced hepatotoxicity.过氧化物酶体增殖物激活受体α在全氟癸酸诱导的肝毒性中的双重作用。
Arch Toxicol. 2017 Feb;91(2):897-907. doi: 10.1007/s00204-016-1779-7. Epub 2016 Jun 25.
8
Control of steroid 21-oic acid synthesis by peroxisome proliferator-activated receptor alpha and role of the hypothalamic-pituitary-adrenal axis.过氧化物酶体增殖物激活受体α对甾体 21-羧酸合成的调控作用及下丘脑-垂体-肾上腺轴的作用。
J Biol Chem. 2010 Mar 5;285(10):7670-85. doi: 10.1074/jbc.M109.090175. Epub 2009 Dec 23.
9
Alteration of Bile Acid and Cholesterol Biosynthesis and Transport by Perfluorononanoic Acid (PFNA) in Mice.全氟壬酸(PFNA)对小鼠胆汁酸和胆固醇生物合成与转运的影响。
Toxicol Sci. 2018 Mar 1;162(1):225-233. doi: 10.1093/toxsci/kfx237.
10
Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.编辑亮点:氯贝丁酸酯通过依赖 PPARα 的方式增加胆汁酸的胆肠排泄从而降低雄性小鼠肝脏中的胆汁酸。
Toxicol Sci. 2017 Dec 1;160(2):351-360. doi: 10.1093/toxsci/kfx191.

引用本文的文献

1
Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments.《瘙痒求解:胆汁淤积性瘙痒治疗的全面综述》
Biomolecules. 2024 Sep 28;14(10):1227. doi: 10.3390/biom14101227.
2
An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases.过氧化物酶体增殖物激活受体在肝脏疾病中的作用概述
J Clin Transl Hepatol. 2023 Dec 28;11(7):1542-1552. doi: 10.14218/JCTH.2023.00334. Epub 2023 Nov 15.
3
The roles of nuclear receptors in cholesterol metabolism and reverse cholesterol transport in nonalcoholic fatty liver disease.核受体在非酒精性脂肪性肝病的胆固醇代谢和胆固醇逆向转运中的作用。
Hepatol Commun. 2023 Dec 15;8(1). doi: 10.1097/HC9.0000000000000343. eCollection 2024 Jan 1.
4
A transcriptional evaluation of the melanoma and squamous cell carcinoma TIL compartment reveals an unexpected spectrum of exhausted and functional T cells.对黑色素瘤和鳞状细胞癌肿瘤浸润淋巴细胞(TIL)区室的转录评估揭示了意想不到的耗竭型和功能型T细胞谱。
Front Oncol. 2023 Oct 30;13:1200387. doi: 10.3389/fonc.2023.1200387. eCollection 2023.
5
Mitochondrial GpC and CpG DNA Hypermethylation Cause Metabolic Stress-Induced Mitophagy and Cholestophagy.线粒体 GpC 和 CpG DNA 超甲基化导致代谢应激诱导的自噬和胆固醇自噬。
Int J Mol Sci. 2023 Nov 16;24(22):16412. doi: 10.3390/ijms242216412.
6
Current Therapies for Cholestatic Diseases.胆汁淤积性疾病的当前治疗方法。
Biomedicines. 2023 Jun 15;11(6):1713. doi: 10.3390/biomedicines11061713.
7
PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales.用于治疗原发性胆汁性胆管炎的过氧化物酶体增殖物激活受体激动剂:新老故事
J Transl Autoimmun. 2023 Jan 5;6:100188. doi: 10.1016/j.jtauto.2023.100188. eCollection 2023.
8
The serum acylcarnitines profile in epileptic children treated with valproic acid and the protective roles of peroxisome proliferator-activated receptor activation in valproic acid-induced liver injury.丙戊酸治疗的癫痫儿童血清酰基肉碱谱及过氧化物酶体增殖物激活受体激活在丙戊酸诱导肝损伤中的保护作用
Front Pharmacol. 2022 Nov 8;13:1048728. doi: 10.3389/fphar.2022.1048728. eCollection 2022.
9
Suppression of Hepatic PPARα in Primary Biliary Cholangitis Is Modulated by miR-155.原发性胆汁性胆管炎中 PPARα 的抑制受 miR-155 调控。
Cells. 2022 Sep 15;11(18):2880. doi: 10.3390/cells11182880.
10
PPARα: A potential therapeutic target of cholestasis.过氧化物酶体增殖物激活受体α:胆汁淤积的一个潜在治疗靶点。
Front Pharmacol. 2022 Jul 18;13:916866. doi: 10.3389/fphar.2022.916866. eCollection 2022.

本文引用的文献

1
Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎小鼠中磷脂和胆汁酸动态平衡的破坏。
Hepatology. 2012 Jul;56(1):118-29. doi: 10.1002/hep.25630. Epub 2012 Jun 6.
2
Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients.癌症患者中有机阳离子转运体 OCT2 对肌酸酐的近曲小管分泌。
Clin Cancer Res. 2012 Feb 15;18(4):1101-8. doi: 10.1158/1078-0432.CCR-11-2503. Epub 2012 Jan 5.
3
Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice.五种胆汁酸对小鼠血清和肝脏胆汁酸浓度及肝毒性的量效反应。
Toxicol Sci. 2011 Oct;123(2):359-67. doi: 10.1093/toxsci/kfr177. Epub 2011 Jul 11.
4
Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus.代谢组学揭示了 SLC6A20 肾脏转运体在 2 型糖尿病的非人类灵长类动物和小鼠模型中的衰减。
J Biol Chem. 2011 Jun 3;286(22):19511-22. doi: 10.1074/jbc.M111.221739. Epub 2011 Apr 12.
5
Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice.胆酸破坏磷脂和鞘脂稳态,导致小鼠胆汁淤积。
Hepatology. 2011 Apr;53(4):1282-93. doi: 10.1002/hep.24193.
6
Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).非靶向代谢组学鉴定肠菌代谢物和潜在尿毒症毒素为有机阴离子转运蛋白 1(Oat1)的底物。
J Proteome Res. 2011 Jun 3;10(6):2842-51. doi: 10.1021/pr200093w. Epub 2011 Apr 22.
7
A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC-ESI-QTOFMS-based metabolomics.基于 UPLC-ESI-QTOFMS 的代谢组学研究全面了解噻替派在小鼠体内的代谢情况。
Biochem Pharmacol. 2011 Apr 15;81(8):1043-53. doi: 10.1016/j.bcp.2011.01.024. Epub 2011 Feb 12.
8
Metabolomics identifies novel Hnf1alpha-dependent physiological pathways in vivo.代谢组学在体内鉴定出新型的Hnf1alpha依赖性生理途径。
Mol Endocrinol. 2010 Dec;24(12):2343-55. doi: 10.1210/me.2010-0130. Epub 2010 Oct 13.
9
Peroxisome proliferator-activated receptor alpha target genes.过氧化物酶体增殖物激活受体α的靶基因。
PPAR Res. 2010;2010. doi: 10.1155/2010/612089. Epub 2010 Sep 26.
10
Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.基于 UPLC-ESI-QTOFMS 的代谢组学研究在小鼠体内环磷酰胺和异环磷酰胺的比较代谢。
Biochem Pharmacol. 2010 Oct 1;80(7):1063-74. doi: 10.1016/j.bcp.2010.06.002. Epub 2010 Jun 10.